Review: taking Vitamin d and Tirosint together


Summary

Drug interactions are reported among people who take Vitamin d and Tirosint together. This review analyzes the effectiveness and drug interactions between Vitamin d and Tirosint. It is created by eHealthMe based on reports of 10,571 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vitamin D

Vitamin d has active ingredients of ergocalciferol. It is often used in vitamin supplementation. (latest outcomes from Vitamin d 47,419 users)

Tirosint

Tirosint has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Tirosint 578 users)

On Sep, 18, 2016

10,571 people who take Vitamin D, Tirosint are studied.


Number of reports submitted per year:

Vitamin d and Tirosint drug interactions.

Drug effectiveness over time:

Vitamin D:
  • < 1 month: 0.0% - (0 of 17 people)
  • 1 - 6 months: 20.0% - (16 of 79 people)
  • 6 - 12 months: 25.0% - (20 of 79 people)
  • 1 - 2 years: 36.0% - (50 of 138 people)
  • 2 - 5 years: 42.0% - (54 of 126 people)
  • 5 - 10 years: 56.0% - (27 of 48 people)
  • 10+ years: 47.0% - (9 of 19 people)
  • not specified: 0.0% - (0 of 3 people)
Tirosint:
  • < 1 month: 9.0% - (1 of 11 people)
  • 1 - 6 months: 24.0% - (9 of 37 people)
  • 6 - 12 months: 38.0% - (13 of 34 people)
  • 1 - 2 years: 37.0% - (21 of 56 people)
  • 2 - 5 years: 54.0% - (66 of 121 people)
  • 5 - 10 years: 62.0% - (83 of 132 people)
  • 10+ years: 73.0% - (185 of 253 people)
  • not specified: 100.0% - (3 of 3 people)

Drug effectiveness by gender:

Vitamin D:
  • female: 34.0% - (153 of 440 people)
  • male: 33.0% - (23 of 69 people)
Tirosint:
  • female: 57.0% - (321 of 560 people)
  • male: 68.0% - (60 of 87 people)

Drug effectiveness by age:

Vitamin D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 40.0% - (2 of 5 people)
  • 30-39: 28.0% - (15 of 52 people)
  • 40-49: 29.0% - (30 of 102 people)
  • 50-59: 37.0% - (60 of 161 people)
  • 60+: 36.0% - (69 of 187 people)
Tirosint:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 60.0% - (6 of 10 people)
  • 30-39: 48.0% - (29 of 60 people)
  • 40-49: 55.0% - (70 of 127 people)
  • 50-59: 58.0% - (125 of 212 people)
  • 60+: 63.0% - (151 of 236 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • nausea
  • diarrhoea
  • headache
  • feeling abnormal
  • fatigue
  • pruritus
  • pyrexia
  • rash
  • anaemia
1 - 6 months:
  • nausea
  • dizziness
  • fatigue
  • rash
  • chest discomfort
  • night sweats
  • swelling of the ankles - feet - legs
  • hypotension
  • anxiety
  • arthralgia
6 - 12 months:
  • depression
  • swelling of the ankles - feet - legs
  • weight gain
  • hypertension
  • nervousness
  • shortness of breath
  • cardiac failure
  • lightheadedness - fainting
  • low platelet count
  • night sweats
1 - 2 years:
  • fatigue
  • synovial cyst
  • anxiety disorder
  • irritability
  • short-term memory loss
  • diarrhoea
  • hyperkalaemia
  • muscle spasms
  • swollen tongue
  • dizziness
2 - 5 years:
  • depression
  • muscle twitching
  • short-term memory loss
  • fatigue
  • cognitive deterioration
  • dizziness
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • fatigue - chronic
  • tremor
  • tinnitus
5 - 10 years:
  • muscle spasms
  • memory loss
  • depression
  • fatigue
  • hypothyroidism
  • short-term memory loss
  • dizziness
  • ptsd
  • weight increased
  • anxiety
10+ years:
  • insomnia
  • headache - mixed tension migraine
  • arthritis
  • chronic sinusitis
  • fibromyalgia
  • hypersomnia
  • pain exacerbated
  • rheumatoid factor positive
  • weight increased
  • depression
not specified:
  • fatigue
  • nausea
  • diarrhoea
  • drug ineffective
  • headache
  • pain
  • dyspnoea
  • dizziness
  • fall
  • arthralgia

Most common drug interactions by gender *:

female:
  • fatigue
  • nausea
  • headache
  • pain
  • drug ineffective
  • diarrhoea
  • dizziness
  • dyspnoea
  • arthralgia
  • fall
male:
  • fatigue
  • diarrhoea
  • nausea
  • dyspnoea
  • drug ineffective
  • asthenia
  • fall
  • dizziness
  • weight decreased
  • pain

Most common drug interactions by age *:

0-1:
  • c-reactive protein increased
  • infantile spasms
  • infection
  • irritability
  • pyrexia
  • vomiting
  • cardio-respiratory arrest
  • death
  • dyspnoea
  • feeding disorder neonatal
2-9:
  • device related infection
  • acne
  • asthenia
  • cellulitis
  • fall
  • rash papular
  • sepsis
  • therapeutic response unexpected
  • weight increased
  • abnormal behaviour
10-19:
  • headache
  • dyspnoea
  • nausea
  • abdominal pain
  • bone pain
  • dry mouth
  • abdominal pain upper
  • asthenia
  • bronchitis
  • cough
20-29:
  • fatigue
  • dyspnoea
  • depression
  • dizziness
  • headache
  • rash
  • cough
  • nausea
  • arthralgia
  • haemoglobin decreased
30-39:
  • pain
  • nausea
  • fatigue
  • headache
  • vomiting
  • diarrhoea
  • injection site pain
  • drug ineffective
  • pain in extremity
  • asthenia
40-49:
  • fatigue
  • pain
  • nausea
  • headache
  • drug ineffective
  • dizziness
  • injection site pain
  • migraine
  • weight increased
  • diarrhoea
50-59:
  • nausea
  • diarrhoea
  • fatigue
  • headache
  • dyspnoea
  • pain
  • dizziness
  • arthralgia
  • drug ineffective
  • insomnia
60+:
  • fatigue
  • nausea
  • diarrhoea
  • dyspnoea
  • pain
  • headache
  • drug ineffective
  • dizziness
  • fall
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vitamin d and Tirosint?

Can you answer these questions?

More questions for: Vitamin d, Tirosint

You may be interested in these reviews

More reviews for: Vitamin d, Tirosint

On eHealthMe, Vitamin d (ergocalciferol) is often used to treat vitamin supplementation. Tirosint (levothyroxine sodium) is often used to treat hypothyroidism. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.